DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Dehydration - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dehydration (95)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 95   Next >>

Possible Paclitaxel side effects in male

Reported by a physician from United States on 2012-08-23

Patient: male, weighing 100.7 kg (221.5 pounds)

Reactions: Nausea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: no treatment
    Indication: Squamous Cell Carcinoma

Blinded NO Treatment Received
    Dosage: no treatment
    Indication: Squamous Cell Carcinoma

Fluorouracil
    Dosage: 1400 mg/24hrs civ over 120 hours
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-01
    End date: 2012-07-06

Fluorouracil
    Dosage: unk
    Start date: 2012-07-29

Fluorouracil
    Dosage: 1400 mg/24hrs civ over 120 hours
    Start date: 2012-07-15
    End date: 2012-07-20

Hydroxyurea
    Dosage: unk
    Administration route: Oral
    Start date: 2012-07-29

Hydroxyurea
    Dosage: 500 mg, bid
    Administration route: Oral
    Start date: 2012-07-15
    End date: 2012-07-20

Hydroxyurea
    Dosage: 500 mg, bid
    Administration route: Oral
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-01
    End date: 2012-07-06

Paclitaxel
    Dosage: 228 mg qwk
    Start date: 2012-07-15
    End date: 2012-07-20

Paclitaxel
    Dosage: unk
    Start date: 2012-07-29

Paclitaxel
    Dosage: 228 mg qwk
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-02

Placebo
    Dosage: no treatment
    Indication: Squamous Cell Carcinoma

Other drugs received by patient: Fentanyl; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Senna; Bacitracin; Filgrastim; Morphine; Famotidine; Fluconazole; Eucerin; Prochlorperazine; Esomeprazole Sodium; Guaifenesin; Enoxaparin; Amoxicillin and Clavulanate Potassium; Miralax; Lidocaine; Escitalopram; Ondansetron; Rosuvastatin; Docusate; Aquaphor; Hydromorphone Hydrochloride; Nystatin



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-08-22

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Other drugs received by patient: Zamanon; Marinol; Metformin; Maxolon



Possible Paclitaxel side effects in 60 year old female

Reported by a physician from United States on 2012-08-10

Patient: 60 year old female, weighing 54.3 kg (119.4 pounds)

Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia

Drug(s) suspected as cause:
Herceptin
    Start date: 2012-06-15
    End date: 2012-06-15

Herceptin
    Start date: 2012-07-09

Herceptin
    Dosage: cyclic on day 1,8,15 and 24
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Neratinib
    Dosage: c1d8
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Neratinib
    Dosage: c1d1
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Paclitaxel
    Dosage: cyclic on day 1,8 and 15 (c1d8)
    Start date: 2012-06-15
    End date: 2012-06-15

Paclitaxel
    Dosage: c1d1
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08



Possible Paclitaxel side effects in male

Reported by a physician from United States on 2012-08-03

Patient: male, weighing 100.7 kg (221.5 pounds)

Reactions: Nausea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: no treatment received
    Indication: Squamous Cell Carcinoma

Blinded NO Treatment Received
    Dosage: no treatment received
    Indication: Squamous Cell Carcinoma

Fluorouracil
    Dosage: 1400 mg/24hrs civ over 120 hours
    Start date: 2012-07-15
    End date: 2012-07-20

Fluorouracil
    Dosage: 1400 mg/24hrs civ over 120 hours
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-15
    End date: 2012-07-06

Hydroxyurea
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-01
    End date: 2012-07-06

Hydroxyurea
    Dosage: 500 mg, unk
    Administration route: Oral
    Start date: 2012-07-15
    End date: 2012-07-20

Paclitaxel
    Dosage: 228 mg qwk
    Start date: 2012-07-15
    End date: 2012-07-20

Paclitaxel
    Dosage: 228 mg qwk
    Indication: Squamous Cell Carcinoma
    Start date: 2012-07-02

Placebo
    Dosage: no treatment received
    Indication: Squamous Cell Carcinoma

Other drugs received by patient: Bacitracin; Fentanyl Citrate; Miralax; Escitalopram; Senna-Mint WAF; Famotidine; Filgrastim; Fluconazole; Eucerin; Aquaphor; Prochlorperazine; Ondansetron; Lidocaine; Morphine Sulfate; Amoxicillin and Clavulanate Potassium; Neosporin (Neomycin Sulfate / Polymyxin B Sulfate); Rosuvastatin



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-08-02

Patient: female, weighing 110.1 kg (242.2 pounds)

Reactions: Dyspnoea, Chest Pain, Tachycardia, Dehydration, Suicidal Ideation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 800 mg

Paclitaxel
    Dosage: 380 mg



Possible Paclitaxel side effects in 56 year old female

Reported by a physician from United States on 2012-07-27

Patient: 56 year old female

Reactions: Abdominal Pain, Vomiting, Nausea, Dehydration, Wound Complication

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: cycle=21 days (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-06-13

Bevacizumab
    Dosage: cycle=21 days (cycle 1-6)
    Start date: 2012-03-12

Carboplatin
    Dosage: cycle=21 days (cycle 1-6), auc= 6 on day 1
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-06-13

Docetaxel
    Dosage: cycle=21 days (cycle 1-6)
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-06-13

Paclitaxel
    Dosage: cycle=21 days (cycle 1-6), over 3 hours day 1
    Indication: Ovarian Epithelial Cancer
    Start date: 2011-06-13



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 123.8 kg (272.4 pounds)

Reactions: Syncope, Urinary Tract Infection, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-05

Cisplatin
    Dosage: 25 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2012-01-05

Paclitaxel
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2012-01-05



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 54.2 kg (119.2 pounds)

Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia

Drug(s) suspected as cause:
Neratinib
    Dosage: 200 mg, 1x/day (c1d8)
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Neratinib
    Dosage: c1d1
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Paclitaxel
    Dosage: c1d1
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08

Paclitaxel
    Dosage: 120 mg, cyclic on day 1 ,8 and 15 (c1d8)
    Start date: 2012-06-15
    End date: 2012-06-15

Trastuzumab
    Dosage: 4 mg/kg, (200/100 mg) cyclic on day 1, 8, 15 and 24 (c1d8)
    Start date: 2012-06-15
    End date: 2012-06-15

Trastuzumab
    Dosage: c1d1
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-08



Possible Paclitaxel side effects in 63 year old female

Reported by a physician from United States on 2012-07-18

Patient: 63 year old female, weighing 122.7 kg (270.0 pounds)

Reactions: Vomiting, Nausea, Pain, Anaemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Skin Ulcer, Hypomagnesaemia, Dehydration, Hypoalbuminaemia, Hypocalcaemia, Vaginal Infection, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutes on day 1,starting with cycle 2 x6 cycles, no prior radiotherapy
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Avastin
    Dosage: prior radiotherapy, iv over 30-90 minutes on day 1 (

Carboplatin
    Dosage: auc = 5 iv over 30 minutes on day 1 x 6 cycles

Carboplatin
    Dosage: no prior radiotherapy, auc = 6 iv over 30 minutes on day 1 x 6 cycles
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Paclitaxel
    Dosage: prior radiotherapy,over 3 hrs on day 1 x 6 cycles

Paclitaxel
    Dosage: no prior radiotherapy, iv over 3 hrs on day 1 x 6 cycles
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Other drugs received by patient: Arixtra; Percocet; Lyrica



Possible Paclitaxel side effects in 55 year old female

Reported by a physician from Germany on 2012-07-16

Patient: 55 year old female

Reactions: Vomiting, Diarrhoea, Dehydration, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 50 mg/m2, unk
    Indication: non-Small Cell Lung Cancer Stage Iiib
    Start date: 2012-05-22
    End date: 2012-05-22

Cisplatin
    Dosage: 50 mg/m2, unk
    Indication: non-Small Cell Lung Cancer Stage Iiia
    Start date: 2012-05-15
    End date: 2012-05-15

Paclitaxel
    Dosage: 175 mg/m2, unk
    Indication: non-Small Cell Lung Cancer Stage Iiia
    Start date: 2012-05-15
    End date: 2012-05-15

Paclitaxel
    Indication: non-Small Cell Lung Cancer Stage Iiib



Possible Paclitaxel side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-16

Patient: male, weighing 104.0 kg (228.8 pounds)

Reactions: Dehydration, Pyrexia, Blood Sodium Decreased, Decreased Appetite, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 900 mg

Cetuximab (Erbitux) 537 MG
    Dosage: 537 mg

Paclitaxel
    Dosage: 462 mg



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-05

Patient: female, weighing 54.2 kg (119.2 pounds)

Reactions: Mucosal Inflammation, Dehydration, Hypokalaemia

Drug(s) suspected as cause:
Neratinib
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-20

Paclitaxel
    Dosage: 120 mg, day 1,8,15
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-15

Trastuzumab
    Dosage: 200/100 mg daily 1/8,15,24
    Indication: Breast Cancer Metastatic
    Start date: 2012-06-08
    End date: 2012-06-15



Possible Paclitaxel side effects in male

Reported by a physician from United States on 2012-07-04

Patient: male, weighing 71.7 kg (157.7 pounds)

Reactions: Cardio-Respiratory Arrest, Pneumonia, Dehydration, Atrial Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Indication: Squamous Cell Carcinoma

Blinded NO Treatment Received
    Dosage: unk
    Indication: Squamous Cell Carcinoma

Cisplatin
    Dosage: 140.25 mg, q21d
    Indication: Squamous Cell Carcinoma
    Start date: 2010-11-30

Comparator Cetuximab
    Dosage: 467.5 mg, unk
    Indication: Squamous Cell Carcinoma
    Start date: 2010-12-07

Paclitaxel
    Dosage: 327.3 mg, q21d
    Indication: Squamous Cell Carcinoma
    Start date: 2010-11-30

Placebo
    Dosage: unk
    Indication: Squamous Cell Carcinoma

Rad001
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Squamous Cell Carcinoma
    Start date: 2010-12-07

Other drugs received by patient: Nicotine; Xalatan; Symbicort; Tiotropium Bromide; Enzymes; Albuterol; Proventil; Enoxaparin; Dexamethasone Sodium Phosphate; Trusopt



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-06-27

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Neoplasm Progression, Hyponatraemia, Hypokalaemia, Renal Impairment, Fatigue, Neoplasm Malignant, Skin Lesion, Sepsis, Dehydration, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10

Other drugs received by patient: Maxolon; Marinol; Zamanon; Metformin HCL



Possible Paclitaxel side effects in 55 year old female

Reported by a physician from Germany on 2012-06-22

Patient: 55 year old female

Reactions: Vomiting, Diarrhoea, Dehydration, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: non-Small Cell Lung Cancer Stage Iiib

Cisplatin
    Dosage: 50 mg/m2,unk
    Indication: non-Small Cell Lung Cancer Stage Iiia
    Start date: 2012-05-15

Paclitaxel
    Indication: non-Small Cell Lung Cancer Stage Iiib

Paclitaxel
    Dosage: 175 mg/m2,unk
    Indication: non-Small Cell Lung Cancer Stage Iiia
    Start date: 2012-05-15

Vinorelbine
    Dosage: unk
    Indication: non-Small Cell Lung Cancer Stage Iiia

Vinorelbine
    Indication: non-Small Cell Lung Cancer Stage Iiib



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-06-19

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Renal Impairment, Fatigue, Neoplasm Malignant, Dehydration, Sepsis, Skin Lesion, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Other drugs received by patient: Maxolon; Marinol; Zamanon; Metformin HCL



Possible Paclitaxel side effects in 56 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13

Patient: 56 year old female, weighing 85.7 kg (188.5 pounds)

Reactions: Electrocardiogram ST-T Change, Blood Potassium Decreased, Dehydration, Hypotension, Cardiac Enzymes Increased, Breast Cancer Female, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine
    Dosage: (10 mg, 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-03-03

Cyclophosphamide
    Dosage: 600 mg/m2, day 1 of c 5-8, intravenous
    Indication: Breast Cancer
    Start date: 2012-03-27
    End date: 2012-05-29

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, day 1 of c# 5-8, intravenous
    Indication: Breast Cancer
    Start date: 2012-03-27
    End date: 2012-05-29

Hydrochlorothiazide
    Dosage: (125 mg, 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-10-21

Lisinopril
    Dosage: (20 mg, 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-10-21

Neratinib
    Dosage: (240 mg, 1 d), oral
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-12-12
    End date: 2012-03-26

Paclitaxel
    Dosage: 80 mg/m2, cyclic, day 1, 8, 15 of c#1-4; intravenous
    Indication: Breast Cancer
    Start date: 2011-12-12
    End date: 2012-03-13

Other drugs received by patient: Zantac



Possible Paclitaxel side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: 60 year old female, weighing 79.8 kg (175.6 pounds)

Reactions: Metastases To Chest Wall, Vomiting, Cellulitis, Pain in Extremity, Nausea, Metastases To Lymph Nodes, Culture Stool Positive, Fatigue, Diarrhoea, Dehydration, Lymphoedema, Candidiasis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 80 mg/m2 over 1 hr, 1 in 28 days, iv drip
    Indication: Breast Cancer
    Start date: 2005-05-04

Tarceva
    Dosage: 100 mg, uid/qd, oral
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2005-05-04

Trastuzumab (Trastuzumab) Injection
    Dosage: 2 mg/kg over 30 min, 1 in 28 days, iv nos
    Indication: Breast Cancer
    Start date: 2005-05-04



Possible Paclitaxel side effects in 60 year old female

Reported by a individual with unspecified qualification from United States on 2012-06-01

Patient: 60 year old female, weighing 79.7 kg (175.3 pounds)

Reactions: Fatigue, Diarrhoea, Dehydration, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer

Paclitaxel
    Indication: Breast Cancer

Tarceva
    Administration route: Oral
    Indication: Breast Cancer



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-05-29

Patient: female, weighing 72.7 kg (159.9 pounds)

Reactions: White Blood Cell Count Decreased, Vomiting, Nausea, Anaemia, Toxicity To Various Agents, Fall, Syncope, Dehydration, Presyncope, Dizziness, Blood Creatinine Increased, Thrombocytopenia, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 395 mg
    End date: 2012-03-27

Paclitaxel
    Dosage: 160 mg
    End date: 2012-04-10



Possible Paclitaxel side effects in

Reported by a individual with unspecified qualification from United States on 2012-05-28

Patient:

Reactions: Pain, Mental Status Changes, Pulmonary Embolism, Constipation, Neuropathy Peripheral, Fatigue, Dyspepsia, Oral Candidiasis, Oedema, Decreased Appetite, Hypovolaemia, Blood Alkaline Phosphatase Increased, Vomiting, Dysphagia, Nausea, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Brachial Plexopathy, Anxiety, Mucosal Inflammation, Insomnia, Aspartate Aminotransferase Increased, Dehydration, Neutropenia

Drug(s) suspected as cause:
Paclitaxel
    Dosage: on days 1-8
    Indication: Breast Cancer Metastatic

Xeloda
    Dosage: on days 1-15
    Administration route: Oral
    Indication: Breast Cancer Metastatic



Possible Paclitaxel side effects in male

Reported by a physician from United States on 2012-05-22

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Axitinib
    Dosage: 3 mg, 2x/day
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-01-31

Carboplatin
    Dosage: 430 mg, auc4
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-01-31

Paclitaxel
    Dosage: 125 mg/m2, cyclic, every 3 weeks
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-01-31

Other drugs received by patient: Atenolol; Lisinopril; Maxidex; Ativan; Tylenol; Zetar; Acidophilus; Nystatin; Tricor; Pradaxa; Vitamin D



Possible Paclitaxel side effects in 55 year old male

Reported by a consumer/non-health professional from Ireland on 2012-05-18

Patient: 55 year old male

Reactions: Blood Bilirubin Increased, Anion GAP Increased, Blood Calcium Increased, Thyroxine Free Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Blood Sodium Decreased, Renal Failure Acute, Decreased Appetite, Blood Chloride Decreased, Hyperglycaemia, Blood Thyroid Stimulating Hormone Decreased, Globulins Increased, Autoimmune Disorder, Haemoglobin Decreased, Diarrhoea, Dehydration, Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded: Ipilimumab
    Dosage: last dose received on 26-apr-2012
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-24

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-24

Placebo
    Indication: non-Small Cell Lung Cancer



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-05-17

Patient: female

Reactions: Diarrhoea, Dehydration, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Docusate Sodium
    Indication: Product Used FOR Unknown Indication

Erlotinib Hydrochloride
    Dosage: cycle every 28 days
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-10-19

Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-10-17

Magnesium NOS
    Indication: Product Used FOR Unknown Indication

Metoclopramide Hydrochloride
    Indication: Product Used FOR Unknown Indication

Paclitaxel
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-10-17



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-05-14

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Fatigue, Renal Impairment, Neoplasm Malignant, Sepsis, Skin Lesion, Dehydration, Cardiac Arrest, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Other drugs received by patient: Metformin HCL; Marinol; Zamanon; Maxolon



Possible Paclitaxel side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from Ireland on 2012-05-13

Patient: 55 year old male

Reactions: Diarrhoea, Dehydration, Colitis, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded: Ipilimumab
    Dosage: last dose received on 26-apr-2012
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-24

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-02-24

Placebo
    Indication: non-Small Cell Lung Cancer



Possible Paclitaxel side effects in 73 year old

Reported by a physician from United States on 2012-04-30

Patient: 73 year old

Reactions: Hyperkalaemia, Diarrhoea, Dehydration, Haematuria, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer Metastatic
    Start date: 2008-12-31

Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2008-10-31

Herceptin
    Dosage: maintainance dose
    Start date: 2008-10-31

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer Metastatic
    Start date: 2008-10-31

Paclitaxel
    Indication: Breast Cancer Metastatic
    Start date: 2008-10-31



Possible Paclitaxel side effects in female

Reported by a physician from South Africa on 2012-04-27

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Vomiting, Diabetic Ulcer, Hyperglycaemia, Hyponatraemia, Neoplasm Progression, Hypokalaemia, Fatigue, Renal Impairment, Neoplasm Malignant, Dehydration, Sepsis, Skin Lesion, Cardiac Arrest, Pneumonitis, Decreased Appetite

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Comparator Trastuzumab
    Dosage: 2 mg/kg, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Paclitaxel
    Dosage: 80 mg/m2, qw
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-10
    End date: 2010-10-04

Other drugs received by patient: Marinol; Maxolon; Zamanon; Metformin HCL



Possible Paclitaxel side effects in 55 year old female

Reported by a individual with unspecified qualification from United States on 2012-04-27

Patient: 55 year old female

Reactions: Myalgia, Syncope, Diarrhoea, Nausea, Exfoliative Rash, Dehydration, Depression, Hypokalaemia

Drug(s) suspected as cause:
Anastrozole
    Dosage: interrupted
    Indication: Product Used FOR Unknown Indication

Docetaxel
    Indication: Breast Cancer
    Start date: 2010-04-09

Herceptin
    Dosage: variable dose
    Indication: Breast Cancer

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-04-09

Lapatinib
    Administration route: Oral

Paclitaxel
    Indication: Breast Cancer
    Start date: 2010-04-09

Other drugs received by patient: Cream NOS; Lisinopril



Possible Paclitaxel side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: 62 year old male, weighing 78.0 kg (171.6 pounds)

Reactions: Death, Vomiting, Nausea, Haemoptysis, Dehydration, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-10-07
    End date: 2009-10-07

Cetuximab
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-10-07
    End date: 2009-10-07

Paclitaxel
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-10-07
    End date: 2009-10-07

Other drugs received by patient: Avalide; Flomax; Lipitor; Guaifenesin + Codeine; Lortab; Phenergan HCL; Zofran



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017